进展期胃癌的新辅助化疗

被引：30

作者：

季加孚

武爱文

机构：

[1] 北京大学临床肿瘤学院外科北京肿瘤医院暨北京市肿瘤防治研究所

来源：

中华胃肠外科杂志 | 2008年 / 02期

关键词：

D O I：

暂无

中图分类号：

R735.2 [胃肿瘤];

学科分类号：

100214 ;

摘要：

<正>手术切除是根治胃癌的主要手段,如何提高手术切除率以改善胃癌患者生存情况一直是研究的焦点。目前,真正通过手术达到根治者仅限于早期和中期的部分胃癌患者,很多患者在手术治疗的基础上,需要积极寻求"辅助治

引用

共 4 条

[1] Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis [J].

Cesana, Giovanni Carlo ;

Romano, Fabrizio ;

Piacentini, Gaia ;

Scotti, Marco ;

Brenna, Ambrogio ;

Bovo, Giorgio ;

Vaghi, Massimo ;

Aletti, Giacomo ;

Caprotti, Roberto ;

Kaufman, Howard ;

Uggeri, Franco .

ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (04) :1295-1304

[2] Response to neoadjuvant chemotherapy and effects of tumor regression in gastric cancer [J].

D'Ugo, D. ;

Persiani, R. ;

Rausei, S. ;

Biondi, A. ;

Vigorita, V. ;

Boccia, S. ;

Ricci, R. .

EJSO, 2006, 32 (10) :1105-1109

[3] Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination [J].

Satoh S. ;

Hasegawa S. ;

Ozaki N. ;

Okabe H. ;

Watanabe G. ;

Nagayama S. ;

Fukushima M. ;

Takabayashi A. ;

Sakai Y. .

Gastric Cancer, 2006, 9 (2) :129-135

[4]

Neoadjuvant Chemotherapy, Surgery, and Adjuvant Intraperitoneal Chemotherapy in Patients With Locally Advanced Gastric or Gastroesophageal Junction Carcinoma: A Phase II Study[J] . Elliot Newman,Milan Potmesil,Theresa Ryan,Stuart Marcus,Spiros Hiotis,Herman Yee,Brendan Norwood,Marc Wendell,Franco Muggia,Howard Hochster.Seminars in Oncology . 2005

← 1 →